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Summary Zinc phthalocyanine substituted with four hydroxyl groups attached to the macrocycle, either
directly or via spacer chains of three or six carbon atoms, were tested for their photodynamic ability to
inactivate Chinese hamster lung fibroblasts (line V-79) in vitro, and to induce regression of EMT-6 tumours
grown subcutaneously in Balb/c mice. Their potential to inflict direct cell killing during photodynamic therapy
was investigated by examining vascular stasis immediately following photoirradiation using fluorescein as a
marker, and also by an in vivo/in vitro EMT-6 cell survival assay. Both of the tetraalkylhydroxy substituted
zinc phthalocyanines are effective photodynamic sensitisers in vivo with the tetrapropylhydroxy compound
exhibiting about twice the activity of the tetrahexylhydroxy analogue. The differences in activities were
accentuated in vitro, the tetrapropylhydroxy compound was two orders of magnitude more potent than the
tetrahexylhydroxy analogue in photoinactivating V-79 cells. The tetrahydroxy compound lacking spacer chains
failed to exhibit photodynamic activity in either system. Tumour response with the active compounds was
preceded by vascular stasis immediate following irradiation which suggests, together with the absence of
activity in the in vivo/in vitro assay, that tumour regression involves an indirect response to the photodynamic
action rather than direct cell killing. These data demonstrate the importance of the spatial orientation of
functional groups around the macrocycle of photosensitisers for their efficacy in the photodynamic therapy of
cancer.
Photodynamic therapy (PDT) (Dougherty, 1987; Henderson
& Dougherty, 1992; Moan & Berg, 1992) of solid tumours is
in phase III clinical trials and is soon likely to be an estab-
lished treatment complementing radio- and chemotherapy.
The photosensitiser currently used, Photofrin II.m (P-II), is a
complex mixture of porphyrin dimers and oligomers, the
active component ofwhich, as yet, remains unidentified. It is,
therefore, of increasing importance that 'second generation'
photosensitisers of known composition and increased photo-
dynamic activity are developed to provide an alternative to
P-II. Phthalocyanines (Pc's) have been proposed as promising
potential PDT agents (for recent reviews see van Lier, 1990;
Rosenthal, 1991) primarily because of the high molar absorp-
tivity of these compounds in the red region of the visible
spectrum (et105 M' cm' at 670-680 nm when fully
monomerised compared to a103M-'cm'1 at 630nm for
P-II) where tissue transmission by visible light is more
efficent. Their photodynamic activities in vivo largely depend
on pharmacokinetics and intratissular distribution pattern
and only limited structure-activity relationships have been
put forth (Paquette & van Lier, 1992). Degree of sulfonation
of Pc's is the most studied structural variable, however, many
alternative substituents are possible and remain unexplored.
An approach towards the synthesis of novel Pc's on the basis
of known structural data, and good photodynamic properties
of related compounds, could be potentially rewarding, and
this is the rationale for the current study.
Berenbaum et al. (1986) tested the ortho, meta and para
isomers of meso-tetra(hydroxyphenyl)porphine (THPP) for
their in vivo photodynamic activity and skin photosensitisa-
tion. Although the m- and o-THPP have very similar photo-
physical properties and similar absorbances at the wavelength
used for PDT (Bonnett et al., 1988), the m-THPP is twice as
effective as o-THPP in sensitising tumours, while o-THPP is
four times as potent as m-THPP in sensitising skin. Doses of
p-THPP and m-THPP that produce equal tumour necrosis
are of the ratio 5:1, while their molar absorbances at the
illuminating wavelengths are of the ratio 2:1. These data
suggest that m-THPP has considerably greater ability than
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the para and ortho isomers to localise at the appropriate site,
indicating that the relative special orientation of the hydroxy
groups around the macrocycle is of crucial importance. On
such accounts we synthesised zinc phthalocyanines (ZnPc)
substituted with hydroxyl groups fused directly, and rigidly,
to the Pc skeleton (i.e. tetrahydroxy zinc phthalocyanine,
ZnPc(OH)4), and with hydroxy groups attached to the Pc by
aliphatic chains of three and six carbons respectively (tetrap-
ropylhydroxy zinc phthalocyanine, ZnPc(prOH)4 and tetra-
hexylhydroxy zinc phthalocyanine, ZnPc(hxOH)4) (Figure 1).
Reddi et al. (1990) showed that unsubstituted ZnPc is photo-
dynamically active when incorporated in liposomes or low
density lipoprotein. The present series of ZnPc derivatives
allowed us to study the effect of increasing distances and
freedom of movement for the four hydroxyl groups on
photodynamic activities both under in vitro and in vivo condi-
tions. Certain aspects of the mechanism of action were also
investigated using an in vivo/in vitro assay, and the assess-
ment of vascular occlusion immediately following PDT.
Materials and methods
Photosensitisers
Synthesis of ZnPc(OH)4 has been described in detail else-
where (Rosenthal et al., 1987). The ZnPc(prOH)4 and ZnPc
(hxOH)4 were prepared from 4-iodophthalonitrile (Marccuc-
cio et al., 1985) by palladium catalysed alkynation, followed
by catalytic hydrogenation over 10% palladium on charcoal
to give 4-(propylhydroxy)phthalonitrile and 4-(hexylhydroxy)-
phthalonitrile, both of which condensed cleanly with zinc
metal at 170°C to give ZnPc(prOH)4 and ZnPc(hxOH)4
respectively. The final products were characterised by their
absorbance and mass spectra. ZnPc(prOH)4: )A. (log 8) =
675 nm (5.48); FAB-MS, M+ (%) = 810 (100). ZnPc(hxOH)4:
Amax (log a) = 673 nm (5.4); FABS-MS, M+ (%) = 978 (100).
Full details of these syntheses will be published elsewhere.
Photofrin II.m was obtained from Quadralogic Technologies
Inc., Vancouver, BC, Canada. Tetrasulphonated zinc
phthalocyanine (ZnPcS4) was prepared by the condensation
method, as previously described (Ali et al., 1988).
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Figure 1 Chemical structures m-THPP a, ZnPc(OH)4 (b: x = 0), ZnPc(prOH)4 (b: x = 3) and ZnPc(hxOH)4 (b: x = 6).
Animal experiments
Animal experiments were conducted following the recom-
mendations of the Canadian Council on Animal Care and of
an in-house ethics committee. The animals were allowed free
access to water and food throughout the experiments. Female
Balb/c mice had one tumour transplanted in to the right hind
thigh by intradermal injection of 2 x 105 EMT-6 mouse
mammary tumour cells (obtained from Dr C.-W. Lin, Mas-
sachusetts General Hospital, Boston) suspended in 0.05 ml of
Waymouths' medium (Gibco) (Brasseur et al., 1988). Mice
were used 6-7 days post-inoculation when tumours had
reached a diameter of 3-5 mm. Mice were injected, via the
tail vein, with Pc and P-II in a solution of Cremophore EL
(Sigma), propane-1,2-diol, and saline (10:3:87). Sulfonated Pc
have been shown to reach optimal concentrations in various
rodent tumours at 24-48 h post-injection (Tralau et al.,
1987; Rousseau et al., 1990) and we assumed similar biodis-
tribution pattern for the novel Pc derivatives. After 24 h the
tumour was irradiated with 650-700 nm light (400 J cm-2 at
a fluence rate of 180 mW cm-2) delivered by a 1000 W
Xenon lamp fitted with 10 cm water filter, and LS-700 (Cor-
ion) and 2-58 (Corning) filters. In the case of P-Il a band of
600-650 nm was used at the same fluence, and fluence rate,
using LS-600 (Corion) and 650-FLO7-50 (Ealing) filters.
Light was focused on the tumour with lenses to give a final
beam of 8 mm in diameter. The fluence at the surface of the
tumour was calculated from the area under the absorption
peaks for the monomeric dye solutions in methanol. Tumour
temperature was measured (Brasseur et al., 1987) and rose to
35°C externally and 32°C internally after 10 min, in both
cases the temperature remained constant for the remainder of
the irradiation time. Tumour response was assessed qualita-
tively and followed from initial necrosis (within 24 h), to
cure, and for a follow-up period of 30 days. Tumour cure
was defined as necrosis of the tumour within 48 h, followed
by regrowth of normal tissue in the treatment area and no
recurrence of the neoplasm up to 30 days post irradiation.
Nine mice were used to confirm the minimal dose of dye
needed to reach the cure. No spontaneous regression of the
tumour was noted in a control group of nine mice over the
time course of the experiment.
In vitro photocytotoxicity assay
Cell survival of Chinese hamster lung fibroblasts (line V-79)
was determined by a colony forming assay (Brasseur et al.,
1985). Plated cells were incubated with 1 ml of dye in
medium containing 1% serum for I h in the dark at 37°C in
5% CO2. After removal of the dye solution and washing with
PBS, cells were refed with growth medium and exposed for
4 min to red light from two 500 W tungsten/halogen lamps
(Sylvania FCL) fitted with a refrigerated filter containing
aqueous Rhodamine (OD580= 1.25) and a red filter (26-
4390, Ealing). The fluence over the absorption peaks of the
photoactive monomeric dyes was 2.4AJcm2. The cells were
then incubated at 37°C in 5% CO2 for 6-7 days. The dye
concentration in fIM required for 90% cell mortality, i.e. the
extracellular LD90, was used to quantify the activity of each
dye preparation. Experiments were run at least three times
with three dishes for each concentration point.
In vivo/in vitro assay
The procedure is essentially as described by Henderson
(1990). Balb/c mice were implanted with two EMT-6 tumours
in the hind thighs. When the tumours reached a diameter of
3-5 mm (6-7 days) mice were injected with 10 mol kg ' of
Pc or 1Omgkg' of P-Il in saline containing 10% Cremo-
phore EL and 3% propane-1,2-diol. Twenty-four hours post-
injection of drug animals were sacrificed and the tumours
were excised, minced, and enzymatically digested (30 min in
CaC12 10 mM, proteinase K (Sigma) 6.5 U, micrococcal
(Sigma) 3 U, collagenase (Sigma) 17 U, in 10 ml Hank's
buffer saline solution). The digested preparation was then
filtered through a 200 mesh sieve and centrifuged at 600g for
5 min. Two hundred cells were placed in 6 cm Petri dishes
and incubated for 3 h at 37°C in 5% CO2 in Waymouth's
culture medium to allow adhesion to the support. Cells were
illuminated as described under in vitro photocytotoxicity
assay. Fluences were calculated from the area under the
absorptoin peaks of the monomeric dye in methanol solu-
tion. It is evident that during the cell isolation procedure
loosely bound dye may detach from the cells resulting in an
underestimation of the potential of the dye to inflict direct
cell killing during PDT. However, a positive effect in this
assay strongly indicates the involvement of a direct photo-
dynamic action on the tumour cells as part of the overall
PDT response.
Fluorescein exclusion assay
Animals were prepared as for PDT, but in this case two
tumours were grown, one on each hind thigh. The right
tumour was irradiated while the left (control) tumour was
shielded from light. Immediately following irradiation mice
were injected via the tail vein with 2 mg sodium fluorescein in
0.2 ml phosphate buffered saline. After 2 min mice were
sacrificed and placed under a longwave UV lamp to visualise
areas penetrated by the dye. Any exclusion of fluorescein
from the irradiated area of tumour and surrounding tissue,
relative to the control, was noted and photographed.HYDROXY ZINC PHTHALOCYANINES 1179
Results
The novel compounds ZnPc(OH)4, ZnPc(prOH)4 and ZnPc
(hxOH)4 were initially tested for their capacity to photo-
inactivate V-79 cells under in vitro conditions. As can be seen
from the survival curves in Figure 2, the ZnPc(prOH)4 is
greater than two orders of magnitude more active than the
ZnPc substituted with four hexylhydroxy (ZnPc(hxOH)4) or
sulphonate (ZnPcS4) groups. The derivative substituted with
hydroxyl groups without spacer chains shows little activity
under our experimental conditions, even at the maximum
concentration used (150gM).
The minimum injected dye doses required for 100% cure
of the EMT-6 tumours grown in Balb/c mice are shown in
Figure 3. Data for P-1I and ZnPcS4 are included for com-
parison and dye doses are expressed in terms of mg kg-'
animal body weight to allow for comparison with P-IT for
which the molecular weight is unknown. ZnPc(OH)4 clearly
shows poor photodynamic activity in this system as, even at
the highest injected doses (101mol kg-'; 6.4mg kg-') no
tumour cure could be obtained. ZnPc(prOH)4 induced 100%
tumour cure at doses as low as 0.5 j.mol kg-' (0.4 mg kg-')
representing an improvement of ten times over ZnPcS4 and
25 times over P-II. PDT with ZnPc(hxOH)4 required twice
the injected dose of ZnPc(prOH)4 in order to induce the same
photodynamic tumour response, i.e. 1 gLmol kg-' (1.0 mg
kg-'). With both compounds ZnPc(prOH)4 and ZnPc(hxOH)4
administered at the minimum dose levels, fluorescein injected
immupediately after PDT was excluded from the irradiated
area, indicating that tumour necrosis is preceded by vascular
stasis. Unirradiated control tumours on the same animals
showed strong fluorescence. Failure to observe significant
photosensitised EMT-6 cell killing in vitro after in vivo
administration of the novel dyes, suggests that a relatively
small amount of dye is retained by the tumour cells (Figure
4). Combined with the vascular shut-down observed immedi-
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Figure 3 Minimal injected dye doses (mg kg-') required for
100% cure of EMT-6 tumours on Balb/c mice after identical
PDT protocols. In the case of ZnPc(OH)4 no tumour cure was
observed at the highest dose (10 mol kg-'; 6.4 mg kg-') tested.
Dyes were injected i.v. as Cremophore emulsions, 24 h later the
tumours were irradiated with red light (400 J cm, 180 mW
cm-2; Pc's 650-700 nm; P-lI, 600-650 nm) and tumour response
assessed qualitatively from initial necrosis (24h) to cure.
ately after PDT these data strongly suggest that tumour
necrosis with these dyes results from an initial vascular effect
rather than direct tumour cell killing. In contrast, ZnPcS4
scored in the in vivo/in vitro assay an LD%0 of less than
20 J cm-2 light dose, indicative of a good potential to inflict
direct cell killing during PDT.
Discussion
If advantage is to be taken of the favourable absorption
characteristics of Pc type molecules in PDT it is important
that structure-activity relationships for this class of com-
pound be defined. To date, research conducted in this area
has mainly addressed the effect of the degree of sulphonation
of Pc's on their biodistribution and photodynamic activity
(for a recent review see Paquette and van Lier, 1992). Com-
mercially available aluminium phthalocyanine sulphonate
(AlPcS) has most widely been used for biological studies
(Tralau et al., 1987; Matthews & Cui, 1990; Bedwell et al.,
1991), but consists of a mixture of tetra, tri, di and monosul-
phonated AlPc with an average sulphonation level of approx-
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Figure 2 Photocytotoxicity assay for ZnPc(OH)4 (0), ZnPc
(hxOH)4 (0), ZnPcS4 (-) and ZnPc(prOH)4 (A) with V-79 cells.
Plated cells were incubated with dye solutions in medium con-
taining 1% serum for 1 h in the dark at 37C. After removal of
the dye solution and washing, cells were exposed for 4 min to red
light at a fluence of 2.4 Jcm2, incubated for 6-7 days where-
after colonies were counted.
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Figure 4 In vivo/in vitro assay for ZnPc(OH)4 (0), ZnPc(prOH)4
(A), ZnPc(hxOH)4 (0) and ZnPcS4 (O). EMT-6 cell survival as
a function of the light dose in vitro, 24 h after i.v. injection of
10 lmol kg-' of sensitiser in vivo.
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imately 3.2 and all attendant positional isomers. It has been
shown however that the lower sulphonated derivatives, and
particularly the amphiphilic AlPcS2a (featuring sulphonate
groups on adjacent benzo rings of the Pc macrocycle) localise
in tumour cells whereas the tetrasulphonated analogue is
mainly detected in the stroma of the tumour (Paquette et al.,
1988; Peng et al., 1990; 1991). Thus, in spite of a higher
overall tumour retention of the tri- and tetrasulphonated
derivates as compared to the mono- and disulphonated ana-
logues (Rousseau et al., 1990; Chan et al., 1990), the latter
exhibit better photodynamic properties due to their advan-
tageous intratissular tumour distribution and cell penetration.
These different activities and localisation pattern also cor-
relate well with the action mechanisms. In the case of the
AlPcS2a light and electron microscopy showed that there was
a direct, extensive, photo-damaging action on human tumour
cells (LOX xenographs) grown in athymic nude mice whereas
treatment of AlPcS4 and light resulted initially in a functional
vasogenic response and ultimate damage to the vascular
structure of the tumour (Peng et al., 1990). Simple proce-
dures to prepare AlPcS enriched in the active disulphonated
derivatives have been reported (Ali et al., 1988; Ambroz et
al., 1991) and their in vivo pattern of photosensitisation have
been studied in detail (Nuutinen et al., 1991; Loh et al.,
1992). Addition of hydrophobic tertiary butyl (Paquette et
al., 1991), phthalimidomethyl (Boyle et al., 1992) or benzene
groups (Margaron et al., 1992) on the non-substituted, adja-
cent benzo rings of disulphonated Pc's further enhances the
amphiphilic properties of these drugs resulting in increased
potential for direct cell killing during PDT. Differently sul-
phonated tetraphenylporphins follow similar biodistribution
pattern as the analogous sulphophthalocyanines, with the
derivative featuring two adjacent sulfonates showing the
highest photocytotoxicity (Kessel et al., 1987).
The work of Bonnett et al. (1987) with the meso-tetra-
(hydroxyphenyl)porphins (THPP) yielded structure-activity
relationships of particular interest for the development of Pc
based photosensitizers. Whereas, the o-, m- and p-isomers of
THPP exhibited similar photophysical properties (Bonnett et
al., 1988) large differences were noted in their biological
activities, with the m-isomer showing the highest potency in
sensitising tumours in vivo (Berenbaum et al., 1986). Unlike
the disulphonated phthalocyanines and tetraphenylporphins,
the THPP isomers are symmetric, lipophilic molecules lack-
ing the characteristic amphiphilic properties of the disulpho-
nated photosensitisers. They distribute in tumours similarly
to the main components of P-II with membranes as the
major target and some localisation in the cytoplasm (Peng et
al., 1991). These data suggest that an array of four hydroxyl
groups arranged judiciously around a rigid photosensitising
structure could impart interesting biological activities to our
Pc. As it was difficult to ascertain the exact orientation of the
hydroxy groups in m-THPP, due to the rotational flexibility
of the single bond linking the hydroxyphenyl groups to the
porphine macrocycle, we synthesised three Pc molecules with
distinct differences in the distances between, and flexibility of
the hydroxyl groups (Figure 1). Our tumour response results
indicated that the spatial arrangement and conformational
flexibility of the hydroxyl groups is essential for PDT
efficacy, as ZnPc(OH)4 was found to be completely photo-
dynamically inactive, even at 10 imolkg- injected dose
(twice the dose at which 100% tumour eradication can be
achieved using ZnPcS4). In contrast, tumour cure with
ZnPc(hxOH)4 and ZnPc(prOH)4 was reached at doses 5 and
10 times lower than for ZnPcS4 and up to 25 times lower
than for P-1I. These differences in biological activities are
further accentuated under in vitro conditions using a popula-
tion of rapidly dividing V-79 cells, a pattern previously noted
with isomeric disulfonated Pc's (Brasseur et al., 1988). The
relative photoactivities between the propylhydroxy and hexyl-
hydroxy ZnPc derivatives changes from a factor 2 in vivo to a
factor 102 under in vitro conditions. The ZnPc(OH)4 shows
little activity in both our in vitro and in vivo model. In a
pattern similar to the differences in activity between o-, m-
and p-THPP we see that in both cases the compounds with
hydroxy groups locked rigidly, relative to one another and
the macrocycle (ZnPc(OH)4 and p-THPP) are the least active,
and that allowing some degree of movement to the hydroxy
groups increases this activity. Such correlations are relevant
to recent theoretical considerations put forth by Winkelman
et al. (1993) concerning stereochemical requirements for
photosensitisers to facilitate transport and binding in bio-
logical systems. These authors compared geometrical features
of a number of substituted porphyrins and phthalocyanines
with published biological activities and suggested that there
exists a critical distance of about 1.2 nm between oxygens
(sulphonate, carboxyl or hydroxyl substituents) that charac-
terises the biologically active structures for PDT. The
flexibility of both our alkylhydroxy ZnPc's will allow
confirmations to match such a geometry and particularly the
tetrapropylhydroxy derivative has a high number of low
energy conformers in which two adjacent OH groups are
separated by 1.1-1.2 nm.
Vascular occlusion of the EMT-6 tumours immediately
after PDT with both the ZnPc(prOH)4 and ZnPc(hxOH)4
indicates that tumour regression mainly results from indirect
photodynamic effects. The absence of photodynamic cell kill-
ing in the in vivo/in vitro assay is in line with such a
mechanism and suggest that only low concentrations of these
dyes are retained by the tumour cells. This does however not
exclude the possible presence of labile-bound dye in vivo,
providing direct photodynamic cytotoxicity, as seems to be
the case with m-THPP mediated PDT response (Peng et al.,
1991). Although early PDT-induced hypoxia can severely
limit the potential for direct cell killing of a dye (Henderson
& Fingar, 1989), the ultimate tumour eradication likely
depends upon the effective destruction of the microvascul-
ature in the tumour and the surrounding normal tissue (Fin-
gar & Henderson, 1987). Intratissular localisation pattern of
m-THPP in human melanoma xenografts in nude mice
resembles that of P-IT (Peng et al., 1991), whereas the alkyl-
hydroxy ZnPc's gave similar response pattern at P-IT in our
current assays. This suggests that P-IT, m-THPP, and our
novel ZnPc(prOH)4 and ZnPc(hxOH)4 share the capacity to
induce similar photodynamic action mechanisms, with the
extent of their potential for direct photocytotoxicity in vivo
depending on the actual PDT conditions used.
In conclusion, we have shown that it is possible to extra-
polate structure-activity relationships determined for por-
phyrin based photosensitisers to other photoactive species
with better absorption characteristics. This could allow the
considerable data available on structure-activity relationships
for porphyrins to be applied ot phthalocyanine based photo-
sensitisers and permit a focus of synthetic efforts for the
design of a viable Pc based PDT agent.
This work was supported by the Natural Sciences and Engineering
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